Obsidian Therapeutics Analyst Price Targets - Benzinga

Obsidian Therapeutics Inc

OBXNASDAQ

Trade with Public

Trade with Public

$16.82

-0.27-1.58%

At close: Sep 4, 5:00 PM EST

$17.75

0.935.53%

After Hours: Sep 2, 8:09 AM EST

Overview NewsPrice TargetsFinancials Sentiment Compare Stock Report

Obsidian Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Obsidian Therapeutics (OBX).

Price Target Range — 1 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingOutperform# Analysts2Avg. Consensus PT$43Upside to Avg. PT+139.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 18, 2026	LifeSci Capital	—	Initiate	Outperform	$43
Aug 5, 2026	Piper Sandler	Kelsey Goodwin	Initiate	Overweight	$42

Analyst Ratings News

This Civeo Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Analysts change outlook on top Wall Street names, including initiations, upgrades, and downgrades. Check our analyst ratings page for details.

Avi Kapoor

PRO
Piper Sandler Initiates Coverage On Obsidian Therapeutics with Overweight Rating, Announces Price Target of $42

Piper Sandler analyst Kelsey Goodwin initiates coverage on Obsidian Therapeutics (NASDAQ:OBX) with a Overweight rating and announces Price Target of $42.

Benzinga Newsdesk